Year: 2022

Newsmakers

LIXTE Biotechnology (NASDAQ: LIXT) Announces Preclinical Results of its Collaboration with the Netherlands Cancer Institute, Revealing Striking Anti-Cancer Activity of LB-100 In Novel Drug Combinations

April 12, 2022 admin Comments Off on LIXTE Biotechnology (NASDAQ: LIXT) Announces Preclinical Results of its Collaboration with the Netherlands Cancer Institute, Revealing Striking Anti-Cancer Activity of LB-100 In Novel Drug Combinations

PASADENA, CA, April 12, 2022 — LIXTE Biotechnology Holdings, Inc. (NASDAQ: LIXT), a clinical-stage pharmaceutical company focused on developing and commercializing cancer therapies, announces that Professor René Bernards, Netherlands Cancer Institute (NKI), Amsterdam, presented new data […]

No Picture
Healthcare

Veru’s Novel COVID-19 Drug Candidate Reduces Deaths by 55% in Hospitalized Patients in Interim Analysis of Phase 3 Study; Independent Data Monitoring Committee Halts Study Early for Overwhelming Efficacy

April 11, 2022 admin Comments Off on Veru’s Novel COVID-19 Drug Candidate Reduces Deaths by 55% in Hospitalized Patients in Interim Analysis of Phase 3 Study; Independent Data Monitoring Committee Halts Study Early for Overwhelming Efficacy

— Independent Data Monitoring Committee Unanimously Recommends that Phase 3 Clinical Trial for Sabizabulin for Treatment of Hospitalized COVID-19 Patients at High Risk for ARDS Be Stopped Early Due to Overwhelming Evidence of Efficacy — […]

No Picture
Healthcare

Hoth Therapeutics (NASDAQ: HOTH) mRNA Frame-Shifting Therapeutic, HT-KIT, Proves Effective Against Aggressive Cancer Cells

April 11, 2022 admin Comments Off on Hoth Therapeutics (NASDAQ: HOTH) mRNA Frame-Shifting Therapeutic, HT-KIT, Proves Effective Against Aggressive Cancer Cells

Treatment with HT-KIT prevented cancer cell growth and induced death in neoplastic mast cells over 72 hours HT-KIT inhibits tumor growth and systemic organ infiltration using both an allograft mastocytosis model and a humanized xenograft […]

No Picture
Aerospace & Defense

Momentus (NASDAQ: MNTS) Signs Launch Services Agreements With SpaceX

April 8, 2022 admin Comments Off on Momentus (NASDAQ: MNTS) Signs Launch Services Agreements With SpaceX

Launch reservations establish targeted flight schedule through 2023 SAN JOSE, Calif., April 07, 2022—Momentus Inc. (NASDAQ: MNTS) (“Momentus” or the “Company”), a U.S. commercial space company that plans to offer transportation and other in-space infrastructure […]

No Picture
Newsmakers

Guardforce AI (NASDAQ:GFAI) Initiates Robotics Solutions Upgrades for Hotels Through Mutual Agreement with Blue Pin

April 8, 2022 admin Comments Off on Guardforce AI (NASDAQ:GFAI) Initiates Robotics Solutions Upgrades for Hotels Through Mutual Agreement with Blue Pin

NEW YORK, NY / April 8, 2022 / Guardforce AI Co., Limited (“Guardforce AI” or the “Company”) (NASDAQ:GFAI)(NASDAQ:GFAIW), an integrated security solutions provider, today announced it has entered into a mutual agreement with Blue Pin (HK) Limited […]

No Picture
Newsmakers

Phio Pharmaceuticals (NASDAQ: PHIO) Presents Positive New Data on PH-894 Demonstrating Antitumor Efficacy in Model of PD-1 Refractory Disease at the AACR Annual Meeting 2022

April 8, 2022 admin Comments Off on Phio Pharmaceuticals (NASDAQ: PHIO) Presents Positive New Data on PH-894 Demonstrating Antitumor Efficacy in Model of PD-1 Refractory Disease at the AACR Annual Meeting 2022

MARLBOROUGH, Mass., April 8, 2022 — Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical stage biotechnology company developing the next generation of therapeutics based on its proprietary self-delivering RNAi (INTASYL™) therapeutic platform, today presented positive new preclinical […]

Healthcare

PharmaDrug (OTC: LLMLF) Advances DMT-Analogue Program for Glaucoma with Production of Medical Device Designed to Provide Sustained Control of Elevated Intraocular Pressure

April 7, 2022 admin Comments Off on PharmaDrug (OTC: LLMLF) Advances DMT-Analogue Program for Glaucoma with Production of Medical Device Designed to Provide Sustained Control of Elevated Intraocular Pressure

Prototype medical device engineered to deliver sustained, sub-psychedelic quantities of candidate DMT-analogues In vitro, time dependent drug elution profile evaluated for three candidate molecules Biocompatibility of drug-loaded medical device demonstrates cell-based safety at doses anticipated […]

Healthcare

Nova Mentis (OTC: NMLSF) to Produce Psilocybin Capsules for Phase 2A Clinical Study

April 7, 2022 admin Comments Off on Nova Mentis (OTC: NMLSF) to Produce Psilocybin Capsules for Phase 2A Clinical Study

Manufacturing Contract with the Toronto Institute of Pharmaceutical Technology VANCOUVER, BC, April 7, 2022 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics […]

No Picture
Newsmakers

AITX’s (OTC: AITX) Subsidiary Robotic Assistance Devices Receives Multiple ROSA Order from a Leading Energy Company

April 7, 2022 admin Comments Off on AITX’s (OTC: AITX) Subsidiary Robotic Assistance Devices Receives Multiple ROSA Order from a Leading Energy Company

Detroit, Michigan, April 07, 2022 — Artificial Intelligence Technology Solutions, Inc., (OTC: AITX), today announced that its wholly owned subsidiary Robotic Assistance Devices, Inc. (RAD) has received an order for 4 ROSA security robots from one […]

No Picture
Newsmakers

Tonix Pharmaceuticals (NASDAQ: TNXP) Initiates Enrollment in the RESILIENT Study, a Potentially Pivotal Phase 3 Study of TNX-102 SL for the Management of Fibromyalgia

April 7, 2022 admin Comments Off on Tonix Pharmaceuticals (NASDAQ: TNXP) Initiates Enrollment in the RESILIENT Study, a Potentially Pivotal Phase 3 Study of TNX-102 SL for the Management of Fibromyalgia

Results from Planned Interim Analysis Expected First Quarter 2023 A Positive Outcome in RESILIENT Together with Results from Previous Positive Phase 3 Study RELIEF May Support Submission of an NDA CHATHAM, N.J., April 07, 2022 […]

Newsmakers

Nextech AR (OTC: NEXCF) Expands 3D Patent Portfolio Files Four Pivotal Non-Provisional Utility Patents

April 6, 2022 admin Comments Off on Nextech AR (OTC: NEXCF) Expands 3D Patent Portfolio Files Four Pivotal Non-Provisional Utility Patents

TORONTO, April 06, 2022—-Nextech AR Solutions Corp. (“Nextech” or the “Company”) (OTCQB: NEXCF) (NEO: NTAR) (CSE: NTAR) (FSE: N29), a Metaverse Company and leading provider of augmented reality (“AR”) experience technologies and services is pleased […]

Newsmakers

ORAGIN’s (OTC: OGGFF) Future of Cheese Receives U.S. Food and Drug Administration (FDA) Registration, Allowing for North American Wide Direct Sales

April 6, 2022 admin Comments Off on ORAGIN’s (OTC: OGGFF) Future of Cheese Receives U.S. Food and Drug Administration (FDA) Registration, Allowing for North American Wide Direct Sales

ORAGIN makes stock option grant to a director of the Company with significant industry experience who will take an active role in the development and growth of the Company and its subsidiary Future of Cheese […]